Causality Investigation between Gut Microbiota, Derived Metabolites, and Obstructive Sleep Apnea: A Bidirectional Mendelian Randomization Study

• Published in: Nutrients 2023-10, Vol.15 (21), p.4544
• Main Authors: Yan, Weiheng, Jiang, Miaomiao, Hu, Wen, Zhan, Xiaojun, Liu, Yifan, Zhou, Jiayi, Ji, Jie, Wang, Shan, Tai, Jun
• Format: Article
• Language: English
• Subjects: Amino acids; Analysis; causal inference; Confounding (Statistics); Fatty acids; Genomes; gut microbiota; Human subjects; Hypertension; Hypoxia; inflammation; intestinal immunity; mendelian randomization; Metabolism; Metabolites; Microbiota; Microbiota (Symbiotic organisms); obstructive sleep apnea; Oxidative stress; Probiotics; Risk factors; Sleep apnea; Sleep apnea syndromes; Sulfates; Type 2 diabetes
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15214544

Various studies have highlighted the important associations between obstructive sleep apnea (OSA) and gut microbiota and related metabolites. Nevertheless, the establishment of causal relationships between these associations remains to be determined. Multiple mendelian randomization (MR) analyses were performed to genetically predict the causative impact of 196 gut microbiota and 83 metabolites on OSA. Two-sample MR was used to assess the potential association, and causality was evaluated using inverse variance weighted (IVW), MR-Egger, and weighted median (WM) methods. Multivariable MR (MVMR) was employed to ascertain the causal independence between gut microbiota and the metabolites linked to OSA. Additionally, Cochran’s Q test, the MR Egger intercept test and the MR Steiger test were used for the sensitivity analyses. The analysis of the 196 gut microbiota revealed that genus_Ruminococcaceae (UCG009) (PIVW = 0.010) and genus_Subdoligranulum (PIVW = 0.041) were associated with an increased risk of OSA onset. Conversely, Family_Ruminococcaceae (PIVW = 0.030), genus_Coprococcus2 (PWM = 0.025), genus_Eggerthella (PIVW = 0.011), and genus_Eubacterium (xylanophilum_group) (PIVW = 0.001) were negatively related to the risk of OSA. Among the 83 metabolites evaluated, 3-dehydrocarnitine, epiandrosterone sulfate, and leucine were determined to be potential independent risk factors associated with OSA. Moreover, the reverse MR analysis demonstrated a suggestive association between OSA exposure and six microbiota taxa. This study offers compelling evidence regarding the potential beneficial or detrimental causative impact of the gut microbiota and its associated metabolites on OSA risk, thereby providing new insights into the mechanisms of gut microbiome-mediated OSA development.